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Fibrin Inhibits Peripheral Nerve Remyelination
by Regulating Schwann Cell Differentiation
of Schwann cells toward myelin production are mainly
derived from adherence to an axon destined for myelina-
tion and the basal lamina (Jessen and Mirsky, 1999b).
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The Rockefeller University Extracellular matrix (ECM) molecules of the basal lamina
and their receptors are involved not only in the process1230 York Avenue
New York, New York 10021 of axonal elongation, via interactions with neurons/
axons (Reichardt and Tomaselli, 1991), but also in remy-
elination, via interactions with glial cells (Bunge et al.,
1986; Sobel, 1998). Laminin is a positive regulator ofSummary
neurite growth and Schwann cell migration (Anton et al.,
1994) and it also induces myelination in vitro (EldridgeRemyelination is a critical step for functional nerve
regeneration. Here we show that fibrin deposition in et al., 1989). In addition, receptors of ECM molecules,
such as 1 integrin, promote myelination by Schwannthe peripheral nervous system after injury is a key
regulator of remyelination. After sciatic nerve crush, cells (Feltri et al., 2002; Fernandez-Valle et al., 1994). The
sciatic nerve during regeneration upregulates laminin,fibrin is deposited and its clearance correlates with
remyelination. Fibrin induces phosphorylation of ERK1/2 fibronectin, and specific integrins (Lefcort et al., 1992)
to resemble the constellation of ECM components andand production of p75 NGF low-affinity receptor in
Schwann cells and maintains them in a nonmyelinating integrins that are present during development (Chernou-
sov and Carey, 2000; Vogelezang et al., 1999). All ofstate, suppresses fibronectin production, and pre-
vents synthesis of myelin proteins. In mice depleted these results indicate the importance of the ECM for
myelination.of fibrin(ogen), remyelination of myelinated axons is
accelerated due to the faster transition of the Schwann The composition of the ECM can be altered after nerve
injury by leakage of fibrinogen from the vasculaturecells to a myelinating state. Regulation of fibrin clear-
ance and/or deposition could be a key regulatory (Akassoglou et al., 2000). The tissue injury also causes
a procoagulant state (Friedmann et al., 1999) resultingmechanism for Schwann differentiation after nerve
damage. in conversion of fibrinogen to fibrin, which can be depos-
ited in the matrix (Bugge et al., 1996). In nervous tissue,
fibrin deposition has been reported in lesions of MSIntroduction
patients (Claudio et al., 1995), as well as in experimental
models of CNS (Koh et al., 1993), and PNS demyelinationA fundamental question in cellular neurobiology is the
regulation of nerve regeneration after injury or disease. after injury (Akassoglou et al., 2000) accompanied by
leakage of the blood-nerve barrier. In these cases, there-Functional nerve regeneration requires not only axonal
sprouting and elongation, but also new myelin synthesis. fore, fibrin becomes a new component of the ECM. How-
ever, a role for fibrin in nerve regeneration and newRemyelination is necessary for the restoration of normal
nerve conduction and for the protection of axons from myelin formation has not been investigated.
In a previous study, we examined the degenerationnew neurodegenerative immunologic attacks (Horner
and Gage, 2000). Incomplete remyelination in the adult phase of sciatic nerve injury (Akassoglou et al., 2000).
Mice deficient in the fibrinolytic components tissue plas-human CNS together with axonal damage contributes
to clinical deficits in diseases such as multiple sclerosis minogen activator (tPA) or plasminogen exhibit exacer-
bated damage after sciatic nerve crush. This effect is(MS) (Bjartmar and Trapp, 2001).
In mammals, there are two types of myelinating cells: due to reduced fibrin clearance since fibrin depletion
rescued the exacerbation observed in tPA-deficient mice.Schwann cells in the peripheral nervous system (PNS)
and oligodendrocytes in the central nervous system However, this work did not reveal any information on
the regenerating phase of the injury or on the cellular and(CNS). After a lesion within the PNS, Schwann cells re-
spond to injury by proliferation and further differentiation molecular mechanisms of fibrin action in the nervous
to myelinating cells (Kioussi and Gruss, 1996). In the tissue.
CNS, adult oligodendrocyte precursors are recruited to In our current work, we have focused on sciatic nerve
the sites of the lesion and exhibit a limited capacity for remyelination and demonstrate a novel role for fibrin as
remyelination (Blakemore and Keirstead, 1999). Following a regulator of Schwann cell differentiation. Sciatic nerve
demyelination, successful remyelination by both Schwann crush in mice genetically (Suh et al., 1995) or pharmaco-
cells and oligodendrocyte precursors depends on a com- logically (Akassoglou et al., 2000) depleted of fibrin(ogen)
bination of signals that these cells receive from the inflam- showed an acceleration in the formation of myelinated
matory response and the demyelinated axons. These sig- axons after injury. Schwann cells in fibrin(ogen)-depleted
nals prompt them to first re-enter the cell cycle, and mice also had an earlier onset of myelin gene transcrip-
then differentiate into myelinating cells (Levine et al., tion, downregulation of p75 NGF low-affinity receptor
2001). (p75 NGFR), and elevated production of fibronectin, a
The molecular signals that drive the differentiation beneficial ECM component for Schwann cell maturation.
In vitro experiments demonstrated that fibrin induced
ERK1/2 phosphorylation and downregulated myelin1Correspondence: strickland@rockefeller.edu
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gene expression in Schwann cells and maintained them axonal remyelination was not significant 8 days after
crush, as evidenced by a small number of myelinatedin a proliferating, nonmyelinating state.
These results identify the fibrin matrix as a critical axons (Figure 2A), and there was substantial fibrin depo-
sition evident (Figure 2D). However, at this time, thereregulator of remyelination of peripheral nerves, and pro-
vide a mechanism for how a blood-derived protein can were numerous myelinating axons in fib/ mice (Figure
2B), and as expected, no fibrin deposition (Figure 2E).affect the proliferation and differentiation of myelinating
cells after peripheral injury. Persistent fibrin deposition, To complement this result, we examined nerve remyelin-
ation in mice in which fibrinogen had been depleteddue to vascular leakage or inadequate clearance, might
provide the basis for neuropathologies characterized pharmacologically. Administration of the Malayan pit
viper (Calloselasma rhodostoma) venom protein, an-by reduced myelin formation. If so, strategies aimed at
removing the fibrin matrix could be beneficial in enhanc- crod, leads to consumption of systemic fibrinogen and
drastically reduces plasma fibrinogen levels (Bell et al.,ing remyelination in neurodegenerative and demyelinat-
ing diseases. 1978). Therefore, under these conditions, fibrin deposi-
tion should be diminished. Ancrod was administered to
wild-type mice for 3 days before crush and then through-Results
out the experimental period, without any effects on sur-
vival. Consistent with experiments with genetic depletionFibrin Clearance Correlates with Nerve Repair
of fibrinogen, ancrod treatment significantly enhancedIn our previous work, we demonstrated a correlation of
the number of myelinating axons (Figure 2C), and pre-fibrin deposition with sciatic nerve degeneration (Akas-
vented fibrin deposition (Figure 2F). Quantification ofsoglou et al., 2000). To examine how fibrin deposition
myelinating axons per 0.1 mm2 showed: wild-type con-is regulated during nerve regeneration, we examined
trol, 5.9  0.8; fib/, 22.7  4; wt  ancrod, 25.2  5.8the presence of fibrin at late time points after sciatic
(Figure 2G; difference, p  0.002). Overall, these resultsnerve injury. Uninjured sciatic nerve shows normal axo-
demonstrate that fibrin deposition is an inhibitory factornal morphology (Figure 1A) and no endoneurial staining
for the early phase of sciatic nerve remyelination.for fibrin(ogen) (Figure 1B, arrows in figure indicate vas-
We additionally compared the status of regenerationcular staining). During degeneration after sciatic nerve
in wild-type and fib/ mice at late time points aftercrush, there is collapse of the myelin sheaths and axonal
sciatic nerve crush injury when there was clearance ofdegeneration (Figure 1C). During the degeneration phase,
fibrin in the wild-type mice. We observed that 35 daysfibrin(ogen) immunoreactivity increases in the endoneu-
after crush, both wild-type and fib/ mice showed therium (Figure 1D). At late time points after injury, there
same extent of axonal regeneration and remyelinationare myelinated axons in the nerve with smaller diameter
(data not shown). Overall these results demonstrate thatand thinner myelin sheath (Figure 1E), when compared
fibrin deposition is an inhibitory factor for the onset andto the axons of the adult uninjured nerve (Figure 1A).
early time points of sciatic nerve remyelination and thatDuring the regeneration phase, fibrin(ogen) decreases
its clearance is a physiological mechanism correlatedto uninjured levels (Figure 1F), presumably due to the
with nerve repair.action of tPA, which is induced after crush (Akassoglou
et al., 2000).
To further evaluate fibrin deposition at different time Fibrin Deposition Does Not Affect Axonal
points after injury, we performed Western blot analysis Sprouting or Macrophage Infiltration
using an antibody against - fibrin dimers, which are Functional nerve regeneration after injury is a multistep
formed by the action of the coagulation system on the process that requires axonal regrowth of the damaged
fibrinogen molecule (Chen and Doolittle, 1971; Lorand axons to their targets and remyelination. The analysis
et al., 1969). The uninjured sciatic nerve did not show reported above relied on the detection of myelin to iden-
formation of - dimers, showing that there is no fibrin tify regenerating nerves. Thus, the delayed regeneration
present constitutively (Figure 1G). Four days after injury, in the wild-type mice could be due to retardation of axon
there was a dramatic increased formation of - dimers, elongation or remyelination.
indicating that the tissue during its degeneration phase To identify which aspect of regeneration was affected
has fibrin deposition (Figure 1G). Twenty-five days after by fibrin deposition, we first examined the progress of
crush injury, during the regeneration phase of the nerve, axonal growth after injury. GAP-43 is expressed by de-
there were no - dimers present, demonstrating that the veloping or regenerating axons, and can thus serve as
fibrin formed during the degeneration phase has been a marker for axon sprouting and elongation (Benowitz
removed from the tissue (Figure 1G). Staining the mem- and Routtenberg, 1997). Axonal expression of GAP-43
brane with Ponseau S before immunoblotting showed appears as early as 4 days after sciatic nerve crush
that equal amounts of total proteins were present in the injury (Woolf et al., 1990). Schwann cells can also ex-
blot (Figure 1H). press GAP-43 after injury, but that expression does not
begin until 12 days after injury (Scherer et al., 1994). To
examine whether fibrin depletion affected axonal regen-Fibrin(ogen)-Deficient Mice Show Increased
Myelinated Axons after Sciatic Nerve Injury eration, we stained longitudinal sections of sciatic nerve
8 days after crush injury. As expected, wild-type unin-To assess the involvement of fibrin in axonal remyelina-
tion in vivo, we examined the tissue morphology of the jured mice showed no staining for GAP-43 (Figure 3A).
Eight days after crush injury, both wild-type (Figure 3B)sciatic nerve 1 mm distal of the crush site 8 days after
crush in wild-type mice and mice genetically or pharma- and fibrin-depleted mice (Figure 3C) showed a similar
pattern of axonal staining of GAP-43 and similar extent ofcologically depleted of fibrinogen. In wild-type mice,
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Figure 1. Fibrin Degradation Correlates with
Remyelination after Injury
Immunocytochemistry for fibrinogen showed
only vascular staining in the uninjured sciatic
nerve (B, arrows). Tolouidine blue-stained
semi-thin cross-sections of the sciatic nerve
showed normal histology as demonstrated
by numerous axons tightly packed and sur-
rounded by myelin sheaths (A). Two days
after crush, there was fibrin deposition in the
nerve (D), which correlated with degenera-
tion as detected by collapsed myelin sheaths
and axonal loss (C). During the remyelination
phase, 21 days after the crush injury, fibrin
deposition was cleared (F) and its immunore-
activity dropped to uninjured wild-type levels
(B). At this time, regenerating axons with
small diameter and thin myelin sheath ap-
peared (E). (G) Immunoblot for fibrin on sciatic
nerve protein extracts showed absence of fi-
brin in the uninjured nerve, dramatic fibrin
deposition during degeneration (4 days after
crush injury), and clearance during regenera-
tion (25 days after crush injury). (H) Ponseau
staining demonstrated equal protein loading
between samples. Bar: 150 m (B, D, and F);
20 m (A, C, and E).
axonal elongation. To further verify the axonal pattern of observed in the number of the axons that had reached
the distal tip of the nerve between wild-type (FigureGAP-43 immunostaining, we stained longitudinal sections
of wild-type and fibrin-depleted mice for GAP-43 and neu- 3H) and fibrin-depleted mice (Figure 3I). Quantitation
of GAP-43-positive axons showed that there was norofilament, an axon-specific marker (Hsieh et al., 1994;
Shaw et al., 1985). The morphology of the GAP-43-posi- difference in the number of regenerating axons between
wild-type and ancrod-treated mice 8 days after crushtive axons (Figure 3K) was similar to the morphology of
the neurofilament-positive axons (Figure 3L), suggesting injury (Figure 3J). Similar results were obtained after
examination of fib/ mice (not shown). To examinethat axons are the major source of GAP-43 expression
8 days after crush injury. whether there was a difference at earlier time points,
we examined GAP-43 immunoreactivity 3 and 5 daysTo quantitate if there was a difference in axon sprout-
ing and elongation, we also stained cross-sections of after crush. In both earlier time points, there was no
difference between wild-type mice and wild-type micethe sciatic nerve 1 mm distal to the crush site. Eight
days after crush, sciatic nerves from control (Figure 3E) treated with ancrod in the number of GAP-43-positive
axons (data not shown). Overall, these results indicatedand fibrin-depleted wild-type mice (Figure 3F) showed
a similar number of GAP-43-positive axons, suggesting that the inhibitory effect of fibrin on regeneration after
sciatic nerve injury was not on axonal sprouting andthat axonal sprouting is not affected by fibrin depletion.
To examine whether the elongation rate differed be- elongation.
We examined other possible mechanisms that fibrintween the two groups, GAP-43 staining was performed
on cross-sections of the sciatic nerve 8 mm distal to might affect during peripheral nerve injury. Macro-
phages are known to accumulate in the sciatic nervethe crush site 8 days after crush. No difference was
Neuron
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Figure 2. Fibrin Depletion Accelerates Ap-
pearance of Myelinated Axons after Injury
Eight days after crush injury, wild-type mice
showed sciatic nerve degeneration charac-
terized by axons with collapsed myelin sheaths
and a few myelinated axons (A). At the same
time point, fibrinogen-deficient mice (B) and
wild-type mice treated with ancrod (C) showed
numerous myelinated axons. Fibrin immunore-
activity was present in wild-type mice (D),
with no staining in fib/ (E) and little staining
in ancrod-treated mice (F). (G) shows mor-
phometric analysis of myelinated axons 8
days after sciatic nerve crush. Data are ex-
pressed as means  SEM. Statistical com-
parisons between medians were made with
the Student’s t test. fib/ mice (n  4) and
ancrod-treated wild-type mice (n  4) showed
significantly more myelinated axons com-
pared to control mice (n 6) (p  0.002). Bar:
20 m.
after crush (Stoll et al., 1989) and enhance axonal regen- et al., 2000), probably due to macrophage removal by
local apoptosis (Kuhlmann et al., 2001). Overall, theseeration (Richardson and Lu, 1994). A possible mecha-
nism therefore could be that fibrin inhibits macrophage results suggest that fibrin is not the determining factor
for macrophage infiltration in the sciatic nerve.infiltration in the tissue. In this hypothesis, the number
of macrophages should be higher in fib/ mice, when
compared to wild-type mice. Immunostaining for Mac-1, Fibrin Affects Schwann Cell Proliferation
The observation that fibrin-depleted mice have morea macrophage-specific marker (Ho and Springer, 1982)
on longitudinal (Figure 4A) and cross-sections (Figure newly myelinated axons after injury (Figure 2), but similar
axonal elongation and sprouting (Figure 3), suggested4D) of wild-type nerve showed that there were no macro-
phages in the uninjured nerve. Four days after crush that fibrin deposition might regulate nerve repair at the
level of myelination. Remyelination is a crucial step forinjury, macrophages were increased in both wild-type
(Figure 4B) and fib/ mice (Figure 4C) on longitudinal restoration of function since demyelinated axons may
maintain both their afferent and efferent connectionssciatic nerve sections. Cross-sections of wild-type and
fib/ mice 4 and 8 days after crush injury (Figures 4E, but have poor conduction due to loss of myelin (Horner
and Gage, 2000). Therefore, we examined the effect of4F, 4H, and 4I) showed infiltration of the injured nerve
by macrophages. To verify whether there was a differ- fibrin depletion on the myelinating cells of the sciatic
nerve, the Schwann cells. After sciatic nerve injury,ence in numbers of macrophages, we quantitated the
number of Mac-1-positive cells on cross-sections of Schwann cells proliferate, establish contacts with the
newly formed axons, stop proliferating, and differentiatesciatic nerve (Figure 4G). There was no statistically sig-
nificant difference in the number of macrophages 4 or into myelinating cells (Jessen and Mirsky, 1999a). To
examine whether fibrin affects Schwann cell differen-8 days after crush injury in wild-type and fib/ mice
(Figure 4G). Similar data were obtained using F4/80 (not tiation, we compared their proliferation in the presence
or absence of fibrin 4 days after crush, the peak ofshown), as another macrophage marker (Austyn and
Gordon, 1981), indicating that there is no significant Schwann cell proliferation after sciatic nerve injury
(Bradley and Asbury, 1970). Sciatic nerves of wild-typedifference in the number of macrophages in between
the two genotypes after crush injury. As shown in Figure and fib/ mice were crushed and 4 days after injury,
mice were injected intraperitoneally with BrdU, a thymi-4G, 4 days after injury, the number of macrophages
increased in the nerve of both wild-type and fib/ mice, dine analog that is incorporated in the DNA of cells that
are in S phase of the cell cycle. Two hours after injection,as expected by results described in other studies (Perry
et al., 1987; Stoll et al., 1989). The number of macro- mice were sacrificed and BrdU nuclei were detected
with a biotinylated antibody against BrdU. Fibrin-phages 8 days after injury remained constant (Siebert
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Figure 3. Depletion of Fibrin Does Not Affect
Axonal Sprouting or Elongation
Immunostaining with an antibody against
GAP-43 showed an axonal staining pattern in
longitudinal sections of both wild-type (B)
and fibrin-depleted (C) sciatic nerves 8 days
after crush injury. Cross-sections of sciatic
nerves showed the same extent of axonal
sprouting close to the crush site in wild-type
(E) and fibrin-depleted wild-type mice (F) and
the same number of axons that have elon-
gated toward the distal site of the crush (H
and I). Uninjured sciatic nerve showed no
staining for GAP-43 (A, D, and G). (J) Quantifi-
cation of GAP-43-positive axons 8 days after
crush. Data are expressed as means  SEM.
Wild-type mice treated with ancrod (n  3)
did not show any difference in the number
of GAP-43-positive axons when compared to
control mice (n  4). High power of longitudi-
nal sections of sciatic nerves show GAP-43-
positive axons (K) with the same morphology
as neurofilament-positive axons (L). Bar: 80
m (A, B, and C); 350 m (D to I); 25 m (K
and L).
depleted mice (Figure 5B) had a dramatic decrease in extracellular signal-regulated kinase (ERK), p44 (ERK1)
and p42 (ERK2), using an antibody specific for the phos-the number of proliferating cells compared to wild-type
mice (Figure 5A). In vivo BrdU labeling of wild-type unin- phorylated form of ERK1/2. The ERK1/2 signaling path-
way plays a critical role in the regulation of cell growthjured sciatic nerve showed no proliferating cells (Fig-
ure 5C). To determine if the BrdU nuclei were from and differentiation (Kolch, 2000). ERK1/2 phosphoryla-
tion is induced by the Ras oncogene and blocks cellSchwann cells, we performed double staining using an
antibody against S100, a general Schwann cell marker apoptosis. Since in the presence of fibrin, Schwann cells
showed increased proliferation (Figures 5A and 5E), we(Kioussi and Gruss, 1996). Almost all the cells with BrdU
nuclei were stained for S100 (Figure 5D). Quantification examined if fibrin would affect ERK1/2 phosphorylation.
We compared Schwann cells cultured on laminin, a ma-of the number of BrdU nuclei showed that fibrin-
depleted mice had 50% fewer BrdU cells compared jor component of the ECM of the uninjured nerve, or on
fibrin. Schwann cells cultured 3 days on fibrin showedto wild-type mice (Figure 5E) and this difference was
statistically significant (p 0.01). Eight days after crush, a dramatic increase of phosphorylated ERK1/2 when
compared to cells cultured on laminin (Figure 6A). Thewhen Schwann cell proliferation is still observed at the
injured compared to the uninjured nerve (Bradley and levels of total ERK1/2 were similar in both cells that
grow on laminin and fibrin (Figure 6A), showing thatAsbury, 1970), fib/ mice also had fewer BrdU cells
compared to wild-type mice (data not shown). Overall, the difference in phosphorylated ERK1/2 was due to
regulation of ERK1/2 at the level of phosphorylation andthese results suggest that fibrin regulates Schwann cell
proliferation. not due to differences in total expression of ERK1/2.
We also examined the effect of fibrin on ERK1/2 phos-
phorylation at earlier time points in culture. We per-Fibrin Induces ERK1/2 Phosphorylation
To examine if fibrin regulated a signaling pathway that formed immunoblot analysis from Schwann cell extracts
1 day after plating on fibrin or on laminin. Quantitationaffects proliferation, we examined the two forms of the
Neuron
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Figure 4. Fibrin Depletion Does Not Affect Macrophage Infiltration
Immunostaining for the macrophage marker Mac-1 on longitudinal sections showed macrophages in both wild-type (B) and fib/ (C) mice 4
days after crush injury. Cross-sections of sciatic nerves stained with Mac-1 of wild-type mice 4 days (E) and 8 days after injury (H) showed
no difference in macrophage infiltration when compared to fib/ mice (F and I) at the same time points. Longitudinal (A) and cross-sections
(D) of uninjured sciatic nerves did not show any staining for Mac-1. (G) Quantification of Mac-1-positive macrophages on cross-sections did
not show any difference in the number of Mac-1-positive cells of fib/ mice (n  4) when compared to control mice (n  4) 4 and 8 days
after sciatic nerve crush injury. Data are expressed as means  SEM. Bar: 100 m.
showed a 19-fold increase of phosphorylated ERK1/2 these results suggest that one mechanism by which
fibrin maintains Schwann cells in a proliferating, nonmy-of the cells grown on fibrin versus those on laminin for
1 day (Figure 6B). Longer culture times on fibrin for 3 elinating state is through induction of ERK1/2 phosphor-
ylation.days further increased the levels of ERK1/2 phosphory-
lation up to a 27-fold increase (Figure 6B). Schwann
cells grown on laminin for 3 days also showed a 4-fold Fibrin Regulates Schwann Cell Differentiation
The earlier withdrawal of the Schwann cells from a prolif-increase of ERK1/2 phosphorylation when compared to
Schwann cells grown on laminin for 1 day (Figure 6B). erating state in the absence of fibrin suggested their
early differentiation to myelinating cells. MyelinatingThese results show that fibrin is a potent inducer of
ERK1/2 phosphorylation and that phosphorylation of cells upregulate myelin genes and produce myelin pro-
teins, such as P0 protein and myelin basic protein, inERK1/2 increases with cell culture time.
To examine whether inhibition of ERK1/2 phosphory- contrast to the migrating-proliferating cells. Expression
of these myelin genes can serve as a marker for thelation affects Schwann cell proliferation on fibrin, we
cultured primary Schwann cells in the presence of differentiated state. We investigated whether after in-
jury, sciatic nerves from fibrin-depleted mice expressedU0126, a specific inhibitor in the pathway that leads to
ERK1/2 phosphorylation (Favata et al., 1998). We per- myelin genes earlier than wild-type mice. In situ hybrid-
ization with a P0 cRNA probe showed that 8 days afterformed immunoblot analysis on extracts from Schwann
cell cultured in the presence of the inhibitor and ob- crush, Schwann cells from wild-type mice had not yet
started P0 mRNA expression (Figure 7A), whereas fib/served that U0126 completely inhibited ERK1/2 phos-
phorylation (Figure 6B). After 3 days in culture, the mice had significant P0 mRNA synthesis (Figure 7B). In
addition, we examined P0 mRNA expression in sciaticSchwann cells grew more vigorously on a fibrin matrix
(Figure 6D), when compared to those cultured on laminin nerve extracts using semi-quantitative RT-PCR analysis.
Using specific primers for P0, we performed RT-PCR(Figure 6C). Addition of U0126, the inhibitor of ERK1/2
phosphorylation, had no effect on cells growing on analysis on cDNA prepared from sciatic nerves of mice
in postnatal day 6, adult wild-type, and wild-type andlaminin (Figure 6E). In contrast, addition of U0126 to
Schwann cell cultures growing on fibrin dramatically fib/ 8 days after crush injury, using different cycles for
amplification. RT-PCR for actin was performed on thereduced the number of cells (Figure 6F). Taken together,
Fibrin Is a Negative Regulator of Remyelination
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Figure 5. Fibrin Induces Schwann Cell Prolif-
eration
Four days after sciatic nerve crush, fib/ mice
showed fewer BrdU-positive nuclei (B) than
wild-type mice (A, inset shows a magnifica-
tion of a BrdU nuclei). (C) Uninjured sciatic
nerve did not show BrdU-positive nuclei. (D)
In vivo BrdU labeling (brown) counterstained
with anti-S100 (blue) showed that the BrdU
cells are also positive for the S100 Schwann
cel marker. (E) Quantification of BrdU nuclei
4 days after sciatic nerve crush. Data are ex-
pressed as means  SEM. Statistical com-
parisons between medians were made with
the Student’s t test. fib/ mice (n 4) showed
50% less BrdU nuclei compared to control
mice (n  6) (*p  0.01). Bar: 130 m (A, B,
and C); 25 m (D).
same samples to determine cDNA integrity and amount wild-type mice (Figure 7E). In contrast, fib/ mice show
a dramatic decrease in the production of p75 NGFRbetween samples. As expected, sciatic nerve from P6
showed a high level of P0 expression (Figures 7C and (Figure 7E). Overall, these results show that fibrin pro-
motes the production of p75 NGFR after injury and provide7D) since at this state, the nerve actively myelinates
(Jessen and Mirsky, 1999b). Consistent with our in situ further evidence that Schwann cells in the absence of
fibrin are at a less immature state than in wild-type mice.hybridization data, after injury, sciatic nerve from fib/
mice showed a 3-fold increase in P0 mRNA, when com- Our results that fib/ mice show reduced cell prolifer-
ation raised the possibility that these mice might havepared to wild-type mice (Figures 7C and 7D). To examine
whether fibrin could also have an effect in the expression a reduced number of Schwann cells compared to wild-
type mice. To address this question, we counted totalof P0 in vitro, we cultured Schwann cells in the presence
of forskolin, a cAMP analog that is known to induce myelin nuclei of wild-type and fib/ sciatic nerves at different
time points after the crush (Figure 7F). The total numbergene expression (Lemke and Chao, 1988). We observed
a 2-fold increase of P0 mRNA expression of Schwann cells of nuclei remained constant between the two genotypes.
Our results suggest that wild-type and fib/ mice havecultured on laminin versus those cultured on fibrin. These
results suggest that fibrin both in vivo and in vitro is a the same total number of cells, but the phenotype of
these cells differs. In wild-type mice, Schwann cells aredownregulator of expression of P0 myelin gene.
Since P0 is a marker for differentiated myelinating at a proliferating (Figure 5A), nonmyelinating state (Fig-
ure 7A), while in fib/ mice, they are at a low-proliferatingSchwann cells, we also examined the expression of the
p75 NGFR, a marker that identifies immature Schwann (Figure 5B), myelinating state (Figure 7B). Overall, these
data demonstrate that depletion of fibrin acceleratescells. It is well established that p75 NGFR is strongly
activated by withdrawal of axons (Lemke and Chao, Schwann cell differentiation to a myelinating, nonprolif-
erating state.1988) and its expression correlates with proliferating,
nonmyelin-producing Schwann cells (Zorick and Lemke,
1996). Western blot analysis demonstrated expression Fibrin Inhibits Fibronectin Expression
in the Sciatic Nerveof p75 NGFR in sciatic nerve extracts of postnatal day
6 (Figure 7E). Three or eight days after crush, expression During nerve development and regeneration, the fibro-
nectin level increases, which promotes Schwann cellof p75 NGFR is observed in sciatic nerve extracts of
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Figure 6. Fibrin-Induced Schwann Cell Pro-
liferation Is Mediated through ERK1/2 Phos-
phorylation
(A) Sciatic nerve protein extracts from
Schwann cells grown on laminin or on fibrin
for 3 days were immunoblotted with an anti-
body that recognizes phosphorylated ERK1/2.
Phosphorylated ERK1/2 was detected in
Schwann cells grown on laminin, but a dra-
matic increase was observed in cells that
grow on fibrin. Immunostatining for total
ERK1/2 showed equal levels between sam-
ples. (B) Quantification of immunoblots of ex-
tracts of Schwann cells grown on fibrin for 1
day showed an 19-fold increase of ERK1/2
phosphorylation when compared to Schwann
cells grown on laminin. Addition of U0126, a
specific inhibitor of ERK1/2 phosphorylation,
did not allow phosphorylation of ERK1/2 to
occur. Schwann cells grown on laminin for
3 days showed a 4-fold increase compared
to cells grown on laminin for 1 day, while
Schwann cells grown on fibrin for 3 days
showed a 27-fold increase of ERK1/2 phos-
phorylation. (C) Schwann cells grew on lami-
nin after 3 days in culture and inhibition of
phosphorylation of ERK1/2 by addition of
U0126 does not inhibit their growth (E).
Schwann cells grew vigorously on fibrin (D),
while inhibition of ERK1/2 phosphorylation in-
hibited their growth on fibrin (F).
migration and correlates with their terminal differentia- Western blot analysis for fibronectin on sciatic nerve
protein extracts also demonstrated increased produc-tion to a nonproliferative, myelinating state (Chernousov
and Carey, 2000). Since fibrin maintains Schwann cells tion of fibronectin in wild-type mice treated with ancrod
8 days after crush (Figure 8J). These results suggestin a proliferative state, it was possible that part of this
effect might be mediated through inhibition of fibronec- that fibrin deposition inhibits fibronectin production at
the sciatic nerve after crush.tin expression. To address this question, wild-type and
fib/ sciatic nerves were stained for fibrin, laminin, and To further define fibronectin expression in myelinating
and nonmyelinating nerve, we examined Western blotsfibronectin 8 days after crush injury. Uninjured, wild-
type mice did not show any staining for fibrin (Figure from extracts of sciatic nerves from P6 and adult mice
with a fibronectin-specific antibody. Sciatic nerve pro-8A; Akassoglou et al., 2000), while there was a significant
deposit after crush (Figure 8B). Fib/ mice after injury tein extracts from mice at P6, when active myelination
is robust (Jessen and Mirsky, 1999b), showed strongdid not show any fibrin staining as expected (Figure 8C).
Immunostaining for laminin showed that uninjured wild- production of fibronectin, when compared to sciatic
nerve from adult mice, when myelination is largely com-type sciatic nerve had extracellular laminin (Figure 8D).
After crush, both wild-type (Figure 8E) and fib/ mice pleted (Figure 8K). This result further establishes that
an increase in fibronectin levels correlates with myelina-(Figure 8F) showed similar levels of laminin immunoreac-
tivity, suggesting that fibrin deposition does not affect tion. Fibronectin in the sciatic nerve is synthesized by
Schwann cells (Vogelezang et al., 1999). To examinethe synthesis and deposition of laminin at the sciatic
nerve after injury. Immunostaining for fibronectin showed whether fibrin affects Schwann cell capacity to produce
fibronectin, we cultured Schwann cells on laminin orthat the uninjured, wild-type nerve expressed very little
fibronectin (Figure 8G). After injury, there was an in- on fibrin. After 4 days in culture, we prepared protein
extracts and examined fibronectin production by immu-crease in fibronectin in wild-type nerves (Figure 8H),
and a much larger increase in fib/ nerves (Figure 8I). noblot. While Schwann cells cultured on laminin pro-
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Figure 7. Fibrin Delays Myelin Gene Transcription and Regulates Schwann Cell Differentiation
In situ hybridization for P0 mRNA 8 days after crush showed minimal expression in the wild-type sciatic nerve (A), while P0 mRNA is detected
in fib/ mice (B, inset shows a high magnification of the P0 positive cells). (C). Agarose gel of semi-quantitative RT PCR for P0 and -actin
on sciatic nerve cDNA from P6, wild-type; wild-type and fib/ 8 days after crush sciatic nerves. (D) Graphical representation of the quantified
autoradiography of the RT-PCR normalized for actin showed a 3-fold increase in P0 transcript in the fib/ mice 8 days after crush when
compared to wild-type mice. Quantitation of RT-PCR of forskolin-treated Schwann cells cultured on laminin showed a 2-fold increase of P0
expression, compared to cells cultured on fibrin. (E) Western blot analysis for p75 NGFR showed decreased expression in fib/ mice 3 and
8 days after crush. (F) Counting of total DAPI-stained cell nuclei per 0.02 mm2 showed the same number of cells between wild-type and fib/
mice at three different time points after the crush injury.
duce fibronectin, cells grown on fibrin produced unde- crod had a dramatic increase in the number of cells that
synthesize the fibronectin transcript (Figure 8M), whentectable levels of fibronectin (Figure 8K).
To determine if the inhibition of fibronectin expression compared to wild-type mice (Figure 8L). These data sug-
gest that fibrin deposition after sciatic nerve crush injuryby fibrin was at the mRNA or protein level, we performed
in situ hybridization with a cRNA probe for fibronectin. inhibits expression of fibronectin mRNA and therefore
fibronectin protein production by the Schwann cells.Eight days after crush, wild-type mice treated with an-
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Figure 8. Fibrin Deposition Inhibits Fibronectin Production by Schwann Cells
Eight days after sciatic nerve crush immunostaining for fibrin showed increased deposition in wild-type sciatic nerve (B). Uninjured wild-type
sciatic nerve (A) and crushed fib/ nerve (C) did not show fibrin immunoreactivity. Immunostaining for laminin showed the same levels of
laminin immunoreactivity in wild-type uninjured (D), wild-type crushed (E), and fib/ crushed (F) sciatic nerves. Immunostaining for fibronectin
showed no staining in uninjured sciatic nerve (G), minimal staining in wild-type crushed sciatic nerve (H), and a dramatic increase in staining
in fib/ crushed nerve (I). (J) Immunoblot for fibronectin on sciatic nerve protein extracts showed increased fibronectin production in fibrin-
depleted mice 8 days after crush when compared to wild-type mice. (K) Immunoblot for fibronectin on sciatic nerve protein extracts showed
increased fibronectin production at postnatal day 6, while the adult mouse had minimal levels of fibronectin. Protein extracts from Schwann
cells cultured on laminin and on fibrin showed that there was fibronectin expression in the laminin cultures but not in fibrin cultures. In situ
hybridization for fibronectin mRNA on crushed sciatic nerves showed many more fibronectin-producing cells in the fibrin-depleted mice (M),
compared to wild-type mice (L). Bar: 30 m (A to I); 150 m (L and M).
Discussion thology, can interfere with repair progression by inhib-
iting the differentiation of Schwann cells to a myelinating
state. Our results, and previous experiments, suggestFibrin and Peripheral Nerve Remyelination
Studies on the regulation of nerve regeneration have the following model for the role of fibrin in remyelination
after sciatic nerve injury (Figure 9). (1) Injury leads to afocused on molecules made by glial cells and neurons.
Blood-derived fibrin, which is not present under physio- breakdown of the blood-nerve barrier, and fibrinogen
can leak into the nerve where it is converted into fibrinlogical conditions as a component of the ECM, but which
gains access to nervous tissue through disease or pa- by an activated coagulation pathway (Friedmann et al.,
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Schwann cells increase ERK1/2 phosphorylation, con-
tinue to proliferate, express p75 NGFR, and produce
little fibronectin and P0. This combination of effects re-
tards the formation of new myelinated axons. In this
scheme, the dissolution of fibrin by the tPA/plasminogen
system allows the gradual return of the Schwann cell to
its final, myelinating state. Fibrin clearance would allow
remyelination to eventually occur in wild-type mice,
which would explain why at later time points after injury,
a difference is not observed between wild-type and fib/
mice.
Although fibrin inhibits Schwann cell differentiation,
overall it could play a beneficial role in nervous system
repair. Interaction of Schwann cells with fibrin would
signal that an injury had taken place, and that prolifera-
tion was required for restoration of myelinated nerves.
As long as fibrin remained, indicating that the injury had
not been healed, the cells would maintain their prolifera-
tive, undifferentiated state. The disappearance of fibrin
would in turn signal that the composition of the ECM
had normalized and that myelination could begin. Given
the effect of fibrin on many other pathological situations
(described below), Schwann cells may be an example
of a general concept: that cells may be primed to detect
fibrin so that they can gauge tissue damage, upregulate
the production of proteins of the proteolytic pathway,
and delay repair processes until the tissue has healed
sufficiently to make it appropriate. In cases of chronic
injury and fibrin deposition, or inadequate fibrin clear-
ance, this beneficial mechanism could prove deleterious
due to retardation of repair.
Figure 9. Proposed Mechanism for the Effects of Fibrin in Peripheral Schwann Cell Proliferation, Myelination,
Nerve Remyelination and Fibrin
Myelinating Schwann cells in the adult normal sciatic nerve have The regulation of Schwann cell proliferation is critical for
established axonal contacts and produce myelin that enwraps the myelination. For example, mutations in the NF-1 tumor
axons. After injury, axons degenerate, myelin gets degraded, and
suppressor gene (Cichowski and Jacks, 2001); Krox-fibrin is deposited. Fibrin deposition regulates Schwann cell num-
20, a transcription factor present only in myelinatingbers by affecting two major cell survival pathways: phosphorylation
Schwann cells (Zorick et al., 1999); or the PMP22 myelinof ERK1/2 and upregulation of p75 NGFR. A combined action of the
proliferating ERK1/2 pathway and the p75 NGFR apoptotic pathway gene (Robertson et al., 1997) trigger abnormal Schwann
sustains the Schwann cells at a nonmyelinating state, as evidenced cell proliferation and hypomyelination. Alterations in
by the shut down of myelin genes transcription, such as P0 and the growth factor pathways can also lead to abnormalities
downregulation of the fibronectin transcript. Downregulation of the
in proliferation and myelination. Neuregulin, a trophicP0 or the fibronectin gene could either be due to the increased ERK1/2
factor that promotes Schwann cell proliferation duringphosphorylation as observed in transformed cells (Brenner et al.,
development (Dong et al., 1995), induces indefinite pro-2000), and/or by another mechanism. When fibrin is degraded during
regeneration, ERK1/2 becomes nonphosphorylated, p75 NGFR is liferation in Schwann cells cultured in the absence of
downregulated, fibronectin is produced and deposited in the nerve, hormones in low serum (Mathon et al., 2001), and inhibits
and Schwann cells transcribe myelin genes and remyelination is myelination in neuron-Schwann cell co-cultures (Za-
initiated. Upregulation of P0 associated with downregulation of p75 nazzi et al., 2001). Taken together, these studies suggestNGFR is a characteristic change associated with myelination (Mor-
a reverse correlation between Schwann cell proliferationgan et al., 1991).
and myelination. Our data demonstrate that in addition
to oncogenes, transcription, and growth factors, the
ECM protein fibrin can induce Schwann cell proliferation1999). (2) Coincident with fibrin deposition, tPA is in-
duced in Schwann cells (Akassoglou et al., 2000; Clark et and therefore become a negative regulator of myelin-
ation.al., 1991). (3) Injury stimulates generation of proliferative
Schwann cells, which do not produce myelin compo- The effects of fibrin on Schwann cell proliferation ap-
pear to be mediated through the ras signal transductionnents (Kioussi and Gruss, 1996). This proliferation phase
is necessary to allow Schwann cells to repopulate the pathway via upregulation of ERK1/2 phosphorylation
(p44/42 MAPK). In many cellular systems, activation ofregenerating axon as it elongates. (4) Schwann cells
then establish axonal contacts and differentiate into a the MAPK pathway by trophic factors has been impli-
cated in the regulation of gene transcription (Treisman,nonproliferative state, and begin the production of new
myelin and ECM components. This transition is drama- 1996) associated with proliferation and differentiation
(Cowley et al., 1994). After deposition, fibrin degradationtically inhibited by fibrin. In the presence of fibrin,
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by the tPA/plasmin system could trigger dephosphoryla- venting formation of the appropriate ECM that promotes
tion of ERK1/2 and the differentiation of the Schwann myelination. The establishment of an appropriate ECM
cells to myelin-producing cells. at later time points after crush when fibrin is cleared
The effects of fibrin on Schwann cells may be regu- would facilitate remyelination in wild-type mice.
lated via integrin signaling since activation of the MAP Our results demonstrate an inhibitory role for fibrin in
kinase pathway is mediated by integrins (Aplin et al., remyelination in the PNS after traumatic injuries. Fibrino-
2001; Chen et al., 1994). Fibrin could either mediate gen is not synthesized by nervous system cells, but it
ERK1/2 phosphorylation directly by binding to specific can enter in the nervous tissue when there is a leakage
integrins or indirectly by upregulation of other factors of the blood-nerve barrier (BNB). BNB disruption is con-
that induce ERK1/2 phosphorylation and Schwann cell sidered a key mechanism of inflammatory demyelina-
proliferation. One such factor is interleukin-1, since fibrin tion in traumatic injuries and autoimmune peripheral ner-
enhances transcription of interleukin-1  in blood mono- vous system diseases, such as Guillain-Barre´ syndrome
nuclear cells (Perez et al., 1999; Perez and Roman, 1995). (Hughes et al., 1998; Kieseier et al., 1999). Fibrin(ogen)
In the sciatic nerve, interleukin-1 is secreted by Schwann therefore could be one of the pathogenic components of
cells (Rutkowski et al., 1999), fibroblasts, and macro- BNB disruption that could contribute to nerve damage. A
phages and is one of the major cytokines that regulate deleterious role for fibrin deposition has been shown
the inflammatory response. In addition, interleukin-1  to contribute to degeneration in various pathologies in
induces ERK1/2 phosphorylation (Ng et al., 2001) and other tissues (Busso et al., 1998; Drew et al., 1998; Kitch-
promotes Schwann cell proliferation (Lisak et al., 1994). ing et al., 1997; Tang and Eaton, 1993), including the
A possible effect of fibrin on the cytokine profile of the central nervous system (Inoue et al., 1996; Paterson,
sciatic nerve could be envisaged and this might be an 1976), and it can also delay wound healing (Bugge et
additional mechanism that fibrin could utilize to affect al., 1996). Given the effects of fibrin in the PNS, fibrin
ERK1/2-mediated Schwann cell proliferation. might regulate ERK1/2 phosphorylation and cell survival
While Schwann cell proliferation is less in the absence in other pathologies associated with fibrin deposition.
of fibrin, the total number of cells remains the same. Our observations that defibrinogenated tPA/ mice
This raises the possibility that fibrin not only regulates show enhanced regeneration efficiency (our unpub-
Schwann cell proliferation, but also affects Schwann lished data) provide evidence that clearance of fibrin,
cell survival mechanisms. For example, fibrin induces even in the absence of innate proteolytic activity, en-
p75 NGFR expression, a receptor involved in Schwann hances regeneration capacity. This result suggests that
cell apoptosis (Soilu-Hanninen et al., 1999; Syroid et al., depletion of fibrinogen or prevention of fibrin deposition
2000). Schwann cells proliferate less in fib/ mice, but might improve regeneration in peripheral and possibly
since the expression of p75 NGFR is also lower, they central nervous system injuries. The identification of fi-
would be less prone to apoptosis and therefore their brin deposition as a new inhibitory aspect of regenera-
number would remain constant. A similar mechanism tion may yield additional strategies to promote repair in
for the regulation of Schwann cell number has been the nervous system.
proposed for krox-20/mice (Zorick et al., 1999). During
early postnatal development, krox-20/ mice exhibit
Experimental Procedures
both more proliferation and more apoptosis of Schwann
cells, and the Schwann cell number remains constant Animals and Sciatic Nerve Crush
between wild-type and krox-20/ mice. Therefore, fi- Mice deficient for the fibrinogen A	 chain gene (fib/; Suh et al.,
1995) were of mixed genetic background, and fib/ littermates werebrin, by inducing ERK1/2 phosphorylation and p75
employed as controls in all studies. For the pharmacological deple-NGFR expression, could regulate both proliferation and
tion of fibrinogen, we used C57Bl/6J mice. No differences wereapoptosis after sciatic nerve crush.
observed between C57Bl/6J mice and fib/ mice in the crush injurySince fibrin becomes a component of the ECM after
model. All mice were 8–15 weeks old at the start of the experiment.
injury, it could compete with other components of the The genotype of all mice was confirmed at the end of the experi-
ECM, such as fibronectin. Fibronectin signals primarily ments by PCR analysis of genomic DNA extracted from mice tails.
through heterodimeric integrin receptors binding to arg- Sciatic nerve crush and systemic defibrinogenation with ancrod
delivery via subcutaneous implantation of mini-osmotic pumps weregly-asp (RGD) and adjacent sequences in the central
performed as described (Akassoglou et al., 2000).binding domain (Pytela et al., 1985). Schwann cell migra-
tion on fibronectin is blocked by RGD peptides, sug-
Immunohistochemistrygesting that migration is mediated by an RGD-depen-
Dissected nerves were embedded in Tissue-Tek OCT (Sakura, Tor-dent integrin (Milner et al., 1997). Since each fibrin
rance, CA), then immediately frozen on dry-ice and stored at 70
Cmolecule contains two RGD peptides (Thiagarajan et al.,
until use. Sections were cut longitudinally on a motor-driven Leica
1996), fibrin might act as an antagonist of fibronectin cryostat with a retraction microtome and a steel knife at a cabinet
and possibly other members of the ECM that signal temperature of 20
C. Immunohistochemical staining was per-
through RGD-dependent integrins. formed on cryostat sections (Akassoglou et al., 1998). Primary anti-
Fibrin induction of ERK1/2 phosphorylation could be bodies were as follows: goat anti-human fibrin(ogen) (Chemicon,
Temecula, CA) (1/500); rabbit anti-human fibronectin (Dako, Carpint-responsible for the downregulation of the fibronectin
eria, CA) (1/500); rabbit anti-mouse laminin (Sigma, St. Louis, MO)gene. In Ras-transformed cells, increase of ERK phos-
(1/1000); rabbit anti-GAP-43 (Chemicon) (1/5000); rat anti-mousephorylation blocks induction of fibronectin (Brenner et
Mac-1 (Boehringer-Mannheim) (1/500); rabbit anti-neurofilament H
al., 2000). In this view, as fibrin is cleared from the nerve (Chemicon) (1/500). Bound antibodies were visualized using the avi-
by the PA/plasminogen system, the cells would increase din-biotin-peroxidase complex (Vectastain Elite ABC kit; Vector Lab-
production of fibronectin and differentiate. Therefore, oratories, Burlingame, CA) and 3-amino-9-ethylcarbazole (AEC)
(Sigma) as a chromogen. Staining specificity for the fibrin(ogen)fibrin might affect Schwann cell differentiation by pre-
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antibody was confirmed using tissue from fib/ mice. Staining spec- cm2 of plate. Plates were placed in the incubator for 2 hr and the
formation of gel was detected macroscopically. Schwann cells wereificity for the other antibodies was confirmed using rabbit IgG. Incu-
bation without the first antibody served as a negative control. cultured as described above. After 3 days in culture they were plated
on 6-well plates that were covered either with laminin or fibrin. Cells
were cultured for 1 or 3 days and protein extracts were preparedIn Situ Hybridization for P0 and Fibronectin
with tissue homogenization in SDS lysis buffer. Protein concentra-In situ hybridization was performed as described in Akassoglou et
tion was determined using the Bradford protein assay and equalal., 1998. For the P0 probe, 5-CACTATGCCAAGGGACAAC-3 sense
amounts of protein were loaded on an SDS-PAGE gel. Electrophore-and 5-CAGACATAGTGGGCAAGAC-3 antisense oligonucleotides
sis was performed according to standard procedures and the pro-were used to PCR amplify 175 bp of exon 3 of the P0 gene. For the
teins were transferred to a nylon membrane which was incubatedfibronectin gene, 5-AAACACTTGTCTTTCCACAG-3 sense and 5-
with an antibody against fibronectin (DAKO, 1/5,000), rabbit anti-TCTTATGGTTTGGTCTGG-3 antisense oligonucleotides were used
mouse fibrin(ogen) (kind gift of Jay Degen, Children’s Hospital, Cin-to PCR amplify 324 bp of the fibronectin gene. The PCR products
cinnati, OH), phosphorylated ERK1/2 (Cell Signaling Technology,were cloned using the TA PCR-cloning system (Invitrogen, Carlsbad,
1/1,000), or rabbit anti-p75 NGFR (Chemicon, 1/1,000) followedCA). Cloning was performed in both orientations and accordingly
by incubation with anti-rabbit HRP (Cell Signaling Technology,sense and antisense mRNA probes were produced using the T7
1/10,000). All membranes were stained with Ponsau to assess equalpromoter of the PCR 2.1 vector (Invitrogen).
loading and transfer for all samples. Detection of HRP was per-
formed using SuperSignal West Pico Chemiluminescent SubstrateSemi-Quantitative RT-PCR
(Pierce, Rockford, IL). Autoradiographies were scanned, analyzedTotal RNA was extracted from sciatic nerves and Schwann cell
using Scion Corporate Image Analysis Software, and normalizedcultures using Trizol (Life Technologies, Rockville, MD). cDNA was
levels were used for the calculation of the differences betweengenerated using Superscript II reverse transcriptase (Life Technolo-
different extracts.gies). Amplification of -actin was performed using the 5-GTC
CTGTATGCCTCTGGTC-3 sense and the 5-TCGTACTCCTGCTTG
In Vivo and In Vitro BrdU LabelingCTGAT-3 antisense oligonucleotides. For P0, the primers described
BrdU (Roche, Indianapolis, IN) was dissolved in water and injectedabove were used. PCR reactions were performed in different cycles
intraperitoneally at a concentration of 100 mg/kg. Mice were sacri-(15, 20, and 25). PCR products were run on agarose gels. Agarose
ficed 2 hr after injection. Sciatic nerves were isolated and cryostatgels were transferred to nylon membranes and were processed
blocks were prepared. BrdU nuclei were detected using the BrdUfor hybridization. The 32P DNA probes used for hybridization were
labeling kit (Oncogene Research Products, San Diego, CA). BrdU/prepared by amplification of genomic DNA with the oligonucleotides
S100 double staining was performed as described (Gaiano et al.,for P0 and -actin described above. Hybridization was performed
2000) with the following alterations. Briefly, PFA-fixed cryostat sec-in Rapid Hyb-Buffer (Amersham, UK). Autoradiographies were
tions of BrdU-injected mice were incubated with an antibody againstscanned, analyzed using Scion Corporate Image Analysis Software,
S100 (1:500, Sigma). Immunoreactivity was detected using the alka-and the P0 levels were normalized against actin expression.
line phosphatase ABC kit (Vector) and developed with the Blue
Alkaline phosphatase substrate (Vector). Sections were then pro-Quantification of Myelinated Axons and Total Nuclei
cessed with the BrdU labeling kit, with the modification that insteadEight days after injury, the crushed sciatic nerve was removed and
of acid denaturation, sections were treated with 5 g/ml DNase Iapproximately 2.5 mm above and below the lesion was isolated and
(Sigma) in TBS with 10 nM MgCl2 and 10 nM MnCl2 for 30 minprepared for semi-thin sectioning (Akassoglou et al., 2000). The
at 37
C. BrdU-positive nuclei were detected with DAB (Oncogenenoninjured sciatic nerve (contralateral) served as a control. A mor-
Research Products).phometric grid (100 mm2) was adapted to the microscope and a
minimum of three grids per sample of myelinated axons was
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